Brief: Valneva's IXCHIQ Authorized In Canada For People Aged 12 And Older
18/08/2025 05:59
Aug 18 (Reuters) - Valneva SE VLS.PA: CHIKUNGUNYA VACCINE IXCHIQ® NOW AUTHORIZED IN CANADA FOR INDIVIDUALS AGED 12 AND OLDER Source text: here Further company coverage: VLS.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Valneva SE
See all newsBrief: UK MHRA Withdraws Marketing Authorisation for Ixchiq Chikungunya Vaccine After Safety Review
Valneva falls as UK regulator revokes Ixchiq vaccine authorisation
Brief: Valneva Provides Update On Ixchiq® In The United Kingdom
Valneva surges after EU regulator validates Lyme disease vaccine application
Brief: Pfizer And Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated By European Medicines Agency